US5234957A
(en)
*
|
1991-02-27 |
1993-08-10 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for topical administration of pharmaceutically active agents
|
US5446070A
(en)
*
|
1991-02-27 |
1995-08-29 |
Nover Pharmaceuticals, Inc. |
Compositions and methods for topical administration of pharmaceutically active agents
|
US4975271A
(en)
*
|
1988-12-19 |
1990-12-04 |
Vipont Pharmaceutical, Inc. |
Muscosal delivery systems for treatment of periodontal disease
|
EP0387751B1
(de)
*
|
1989-03-15 |
1994-06-08 |
Nitto Denko Corporation |
Arzneimittel enthaltendes Heftpflaster
|
JPH03236317A
(ja)
*
|
1989-12-06 |
1991-10-22 |
Sansei Seiyaku Kk |
ドパミン誘導体含有経皮用製剤
|
US5246949A
(en)
*
|
1989-12-06 |
1993-09-21 |
Sansho Co., Ltd. |
Preparation for endermism containing dopamine derivatives
|
EP0476156B1
(de)
*
|
1990-04-06 |
1996-08-07 |
Eisai Co., Ltd. |
Feste orale zubereitung mit einer catecholverbindung
|
US5433950A
(en)
*
|
1990-05-07 |
1995-07-18 |
Schering-Plough Healthcare Products, Inc. |
Flexible collodion compositions
|
US5332576A
(en)
*
|
1991-02-27 |
1994-07-26 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for topical administration of pharmaceutically active agents
|
WO1993000113A1
(en)
*
|
1991-06-21 |
1993-01-07 |
Victor Patrick Davidson |
A composition for treating a soft tissue injury
|
US5470874A
(en)
*
|
1994-10-14 |
1995-11-28 |
Lerner; Sheldon |
Ascorbic acid and proanthocyanidine composition for topical application to human skin
|
US5618557A
(en)
*
|
1994-11-22 |
1997-04-08 |
E.R. Squibb & Sons, Inc. |
Prophylactic treatment of allergic contact dermatitis
|
GB9504265D0
(en)
*
|
1995-03-03 |
1995-04-19 |
Medeva Plc |
Corticosteroid-containing pharmaceutical composition
|
US5990179A
(en)
*
|
1995-04-28 |
1999-11-23 |
Alza Corporation |
Composition and method of enhancing electrotransport agent delivery
|
SE9601528D0
(sv)
|
1996-04-23 |
1996-04-23 |
Pharmacia Ab |
Transdermally administered dextromethorphan as antitissue agent
|
US6512010B1
(en)
|
1996-07-15 |
2003-01-28 |
Alza Corporation |
Formulations for the administration of fluoxetine
|
EP0942697A1
(de)
*
|
1996-10-30 |
1999-09-22 |
THERATECH, INC. (a Delaware Corporation) |
Fettsäureester von milchsäuresalzen als penetrationsförderer
|
US6203817B1
(en)
|
1997-02-19 |
2001-03-20 |
Alza Corporation |
Reduction of skin reactions caused by transdermal drug delivery
|
AUPO983897A0
(en)
|
1997-10-17 |
1997-11-06 |
Soltec Research Pty Ltd |
Topical antifungal composition
|
US6398753B2
(en)
|
1998-04-03 |
2002-06-04 |
Mcdaniel David H. |
Ultrasound enhancement of percutaneous drug absorption
|
US6030374A
(en)
*
|
1998-05-29 |
2000-02-29 |
Mcdaniel; David H. |
Ultrasound enhancement of percutaneous drug absorption
|
AUPP310798A0
(en)
*
|
1998-04-22 |
1998-05-14 |
Soltec Research Pty Ltd |
Vehicle system for a composition comprising a piperidinopyrimidine derivative
|
US6265412B1
(en)
*
|
1998-05-26 |
2001-07-24 |
Taisho Pharmaceutical Co., Ltd. |
Minoxidil compositions for external use
|
US7004933B2
(en)
|
1998-05-29 |
2006-02-28 |
Light Bioscience L.L.C. |
Ultrasound enhancement of percutaneous drug absorption
|
US6699497B1
(en)
|
1998-07-24 |
2004-03-02 |
Alza Corporation |
Formulations for the transdermal administration of fenoldopam
|
US6676655B2
(en)
|
1998-11-30 |
2004-01-13 |
Light Bioscience L.L.C. |
Low intensity light therapy for the manipulation of fibroblast, and fibroblast-derived mammalian cells and collagen
|
US6663659B2
(en)
|
2000-01-13 |
2003-12-16 |
Mcdaniel David H. |
Method and apparatus for the photomodulation of living cells
|
US6887260B1
(en)
*
|
1998-11-30 |
2005-05-03 |
Light Bioscience, Llc |
Method and apparatus for acne treatment
|
US6936044B2
(en)
*
|
1998-11-30 |
2005-08-30 |
Light Bioscience, Llc |
Method and apparatus for the stimulation of hair growth
|
US6283956B1
(en)
*
|
1998-11-30 |
2001-09-04 |
David H. McDaniels |
Reduction, elimination, or stimulation of hair growth
|
US20060212025A1
(en)
*
|
1998-11-30 |
2006-09-21 |
Light Bioscience, Llc |
Method and apparatus for acne treatment
|
US9192780B2
(en)
|
1998-11-30 |
2015-11-24 |
L'oreal |
Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders
|
EP1449527A3
(de)
*
|
1998-12-07 |
2004-09-08 |
Elan Pharma International Limited |
Pflaster zur transdermalen Verabreichung von flüchtigen Wirkstoffen
|
US6974588B1
(en)
|
1999-12-07 |
2005-12-13 |
Elan Pharma International Limited |
Transdermal patch for delivering volatile liquid drugs
|
US7179483B2
(en)
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
US20030017181A1
(en)
|
2001-05-31 |
2003-01-23 |
Rood Gloria A. |
Dermatological compositions and methods
|
US20030060422A1
(en)
|
2001-08-31 |
2003-03-27 |
Balaji Venkataraman |
Tannate compositions and methods of treatment
|
US20070281003A1
(en)
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
US7910641B2
(en)
|
2001-10-12 |
2011-03-22 |
Monosol Rx, Llc |
PH modulated films for delivery of actives
|
US20190328679A1
(en)
|
2001-10-12 |
2019-10-31 |
Aquestive Therapeutics, Inc. |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US8900498B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for manufacturing a resulting multi-layer pharmaceutical film
|
US7425292B2
(en)
|
2001-10-12 |
2008-09-16 |
Monosol Rx, Llc |
Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
|
US7357891B2
(en)
|
2001-10-12 |
2008-04-15 |
Monosol Rx, Llc |
Process for making an ingestible film
|
US10285910B2
(en)
|
2001-10-12 |
2019-05-14 |
Aquestive Therapeutics, Inc. |
Sublingual and buccal film compositions
|
US20110033542A1
(en)
|
2009-08-07 |
2011-02-10 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
US11207805B2
(en)
|
2001-10-12 |
2021-12-28 |
Aquestive Therapeutics, Inc. |
Process for manufacturing a resulting pharmaceutical film
|
US7666337B2
(en)
|
2002-04-11 |
2010-02-23 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
US8900497B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for making a film having a substantially uniform distribution of components
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
US8663687B2
(en)
|
2001-10-12 |
2014-03-04 |
Monosol Rx, Llc |
Film compositions for delivery of actives
|
US8765167B2
(en)
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US8758733B2
(en)
|
2002-02-04 |
2014-06-24 |
Allergan, Inc. |
Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
|
US9216183B2
(en)
|
2002-02-04 |
2015-12-22 |
Allergan, Inc. |
Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
|
US7351404B2
(en)
|
2002-02-04 |
2008-04-01 |
Allergan, Inc. |
Method of enhancing hair growth
|
US7022342B2
(en)
|
2002-03-28 |
2006-04-04 |
Andrx Corporation, Inc. |
Controlled release oral dosage form of beta-adrenergic blocking agents
|
US8017150B2
(en)
|
2002-04-11 |
2011-09-13 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
US9561182B2
(en)
|
2003-08-22 |
2017-02-07 |
Cure Pharmaceutical Corporation |
Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
|
JP2006522660A
(ja)
|
2003-04-10 |
2006-10-05 |
ライト バイオサイエンス,エルエルシー |
細胞増殖及び遺伝子発現を調節するためのフォトモジュレーション方法及び装置
|
US20040258742A1
(en)
*
|
2003-04-11 |
2004-12-23 |
Van Osdol William Woodson |
Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
|
CN101247768A
(zh)
*
|
2003-07-31 |
2008-08-20 |
莱特生物科学有限公司 |
用于光动力学治疗烧伤、创伤和相关皮肤病的***和方法
|
US20080020028A1
(en)
*
|
2003-08-20 |
2008-01-24 |
Euro-Celtique S.A. |
Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent
|
WO2005089039A2
(en)
|
2004-02-06 |
2005-09-29 |
Daniel Barolet |
Method and device for the treatment of mammalian tissues
|
US7718674B2
(en)
|
2004-09-27 |
2010-05-18 |
Bridge Pharma, Inc. |
Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
|
US7872050B2
(en)
*
|
2005-03-14 |
2011-01-18 |
Yaupon Therapeutics Inc. |
Stabilized compositions of volatile alkylating agents and methods of using thereof
|
US20110039943A1
(en)
*
|
2005-03-14 |
2011-02-17 |
Robert Alonso |
Methods for treating skin disorders with topical nitrogen mustard compositions
|
US8501818B2
(en)
*
|
2005-03-14 |
2013-08-06 |
Ceptaris Therapeutics, Inc. |
Stabilized compositions of alkylating agents and methods of using same
|
US20060216350A1
(en)
*
|
2005-03-24 |
2006-09-28 |
Dow Gordon J |
Ganglionic blocking agents for the treatment of epithelial diseases
|
WO2007033152A2
(en)
*
|
2005-09-12 |
2007-03-22 |
Conor Medsystems, Inc. |
Composition, system and method for modulating release kinetics in implantable drug delivery devices by modifying drug solubility
|
US20070167526A1
(en)
*
|
2005-12-19 |
2007-07-19 |
Xiaoming Zhang |
Topical mecamylamine formulations for ocular administration and uses thereof
|
CN101389309A
(zh)
*
|
2006-01-20 |
2009-03-18 |
莫诺索尔克斯有限公司 |
用于经粘膜给予活性组分的薄膜绷带
|
US7592458B2
(en)
|
2006-07-21 |
2009-09-22 |
Wright George E |
Dermal anesthetic compounds and pharmaceutical compositions for inducing local anesthesia and mitigating neuropathic pain
|
CA2664097A1
(en)
|
2006-09-20 |
2008-03-27 |
Monosol Rx, Llc |
Edible water-soluble film containing a foam reducing flavoring agent
|
EP2068958B1
(de)
*
|
2006-09-28 |
2016-10-19 |
Cook Medical Technologies LLC |
Medizinische vorrichtung mit einem anästhetikum und verfahren zu ihrer herstellung
|
US20080108824A1
(en)
*
|
2006-09-28 |
2008-05-08 |
Med Institute, Inc |
Medical Devices Incorporating a Bioactive and Methods of Preparing Such Devices
|
WO2008039995A2
(en)
*
|
2006-09-28 |
2008-04-03 |
Vance Products Incorporated, D/Ba Cook Urological Incorporated |
Medical device including a bioactive in a non-ionic and an ionic form and methods of preparation thereof
|
EP3381445B1
(de)
*
|
2007-11-15 |
2023-10-25 |
Amgen Inc. |
Wässrige antikörperformulierung mit stabilisierung durch antioxidantien zur parenteralen verabreichung
|
FR2926721B1
(fr)
*
|
2008-01-30 |
2011-07-22 |
Philippe Perovitch |
Forme galenique pour l'adminsitration par voie trans-muqueuse de triptans
|
HUE043767T2
(hu)
*
|
2008-03-27 |
2019-09-30 |
Helsinn Healthcare Sa |
Alkilezõszerek stabilizált készítményei és alkalmazási eljárásaik
|
US7943187B2
(en)
*
|
2008-05-23 |
2011-05-17 |
Bakr Rabie |
Paeoniflorin preparations and uses thereof for fat reduction
|
US20100204335A1
(en)
*
|
2008-12-01 |
2010-08-12 |
Allergan, Inc. |
Kit and composition for eyelash growth
|
US8475832B2
(en)
|
2009-08-07 |
2013-07-02 |
Rb Pharmaceuticals Limited |
Sublingual and buccal film compositions
|
US9149484B2
(en)
|
2009-11-09 |
2015-10-06 |
Allergan, Inc. |
Compositions and methods for stimulating hair growth
|
KR101769637B1
(ko)
|
2009-11-09 |
2017-08-18 |
알러간, 인코포레이티드 |
모발 성장을 촉진하기 위한 조성물 및 방법
|
CN103209681B
(zh)
|
2010-06-10 |
2017-05-24 |
Mida科技有限公司 |
纳米颗粒薄膜递送***
|
US9149959B2
(en)
|
2010-10-22 |
2015-10-06 |
Monosol Rx, Llc |
Manufacturing of small film strips
|
CA2818610C
(en)
|
2010-11-18 |
2020-02-18 |
Steven Yoelin |
Compositions and methods for hair growth
|
US8859616B2
(en)
|
2011-01-21 |
2014-10-14 |
Allergan, Inc. |
Compounds and methods for enhancing hair growth
|
US20150164765A1
(en)
|
2012-05-17 |
2015-06-18 |
Steven G. Yoelin |
Compositions and methods for hair growth
|
EP2968093A1
(de)
*
|
2013-03-14 |
2016-01-20 |
Allergan, Inc. |
Topische zusammensetzungen mit bimatoprost und verfahren zur anregung des haarwuchses damit
|
EP2970921B1
(de)
|
2013-03-15 |
2018-09-19 |
aTyr Pharma, Inc. |
Histidyl-trna-synthetase-fc-konjugate
|
CN109310646A
(zh)
|
2016-05-05 |
2019-02-05 |
阿奎斯蒂弗医疗股份有限公司 |
增强递送的肾上腺素组合物
|
US11273131B2
(en)
|
2016-05-05 |
2022-03-15 |
Aquestive Therapeutics, Inc. |
Pharmaceutical compositions with enhanced permeation
|